Henrijette Richter
Managing Partner
Works at Sofinnova
Investor profile | Builders Republic
About
Managing Partner at Sofinnova in Copenhagen, Henrijette Richter invests in Series A, Series B, and Growth with check sizes ranging from €1 to €60 million, focusing on a specialized thesis in biotech and therapeutic development. Her portfolio includes notable companies such as Mozart Therapeutics, Muna Therapeutics, and iOmx Therapeutics, where she chairs the board. She also serves on the board of Nitrase Therapeutics and NodThera Limited, where she holds the position of chair. A Postdoctoral Fellow at MIT, she then spent seven years as Investment Director at Novo A/S before joining Sofinnova.
Profile
- Role
- Managing Partner
- Fund
- Sofinnova
- Nationality
- French